Product Details
| Product Name:
AN7973 |
CAS No.:
1620899-32-2 |
| Supply Ability:
10g |
Release date:
2025/10/27 |
Product Introduction
Bioactivity
| Name | AN7973 |
| Description | AN7973 blocks intracellular parasite development and inhibits Cryptosporidium growth. It is orally active, possesses favorable safety, stability, and PK parameters. |
| In vivo | AN7973 (oral gavage; 5-25 mg/kg; once daily) effectively treats both acute and chronic C. parvum infections in murine models by rapidly eliminating the pathogen in vivo. Additionally, AN7973 (oral gavage; 5 mg/kg, 10 mg/kg, 6.67 mg/kg; once daily, twice daily, three times daily) reduces C. parvum fecal shedding, diarrhea, and dehydration in a neonatal calf model of cryptosporidiosis. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | AN7973 | AN 7973 | AN-7973 |
| Inhibitors Related | Picaridin | Flubendazole | Kojic acid | Urethane | Hydroxychloroquine | Metronidazole | Nitazoxanide | 2-Amino-2-methyl-1-propanol | Doxycycline | Fenpyroximate | Coumaran | Cloxiquine |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
-
CAS:2102192-68-5
$213.00 / 1mg
-
CAS:4825-86-9
$156.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$332.00/5mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-10-27 |
United States